JangoBio Revenue and Competitors
Estimated Revenue & Valuation
- JangoBio's estimated annual revenue is currently $3.7M per year.
- JangoBio's estimated revenue per employee is $155,000
Employee Data
- JangoBio has 24 Employees.
- JangoBio grew their employee count by 14% last year.
JangoBio's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Administrative Officer (CAO) | Reveal Email/Phone |
2 | Director Sales & Marketing | Reveal Email/Phone |
3 | Director Cell Biology | Reveal Email/Phone |
4 | Director Business Development. Investor. Member the Board Directors. | Reveal Email/Phone |
5 | Assistant Director Cell Biology | Reveal Email/Phone |
6 | Cell biologist | Reveal Email/Phone |
7 | Research Specialist II | Reveal Email/Phone |
8 | Principal Scientist, Biomanufacturing and Process Development | Reveal Email/Phone |
JangoBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is JangoBio?
JangoBio is developing regenerative therapies to reverse hormone imbalances associated with aging and thereby mitigate the risk of developing a wide range of age-related diseases. Pharmaceutical treatments, such as hormone supplementation, do not address the underlying loss of function, and can have significant side effects.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3M | 24 | -11% | N/A |
#2 | $3.4M | 24 | -17% | N/A |
#3 | $2.4M | 24 | -8% | N/A |
#4 | $3.5M | 28 | 12% | N/A |
#5 | $8.5M | 30 | 3% | N/A |